Stratos Wealth Partners LTD. Sells 1,863 Shares of Astera Labs, Inc. (NASDAQ:ALAB)

Stratos Wealth Partners LTD. cut its holdings in Astera Labs, Inc. (NASDAQ:ALABFree Report) by 16.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 9,761 shares of the company’s stock after selling 1,863 shares during the period. Stratos Wealth Partners LTD.’s holdings in Astera Labs were worth $1,293,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Calamos Advisors LLC bought a new position in Astera Labs in the 4th quarter worth $1,693,000. Renaissance Capital LLC increased its position in Astera Labs by 381.0% in the fourth quarter. Renaissance Capital LLC now owns 114,276 shares of the company’s stock worth $15,136,000 after buying an additional 90,516 shares in the last quarter. Jennison Associates LLC bought a new position in shares of Astera Labs in the fourth quarter worth about $229,991,000. Western Pacific Wealth Management LP purchased a new position in shares of Astera Labs during the 4th quarter valued at about $212,000. Finally, China Universal Asset Management Co. Ltd. bought a new position in shares of Astera Labs during the 4th quarter valued at approximately $3,444,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Stock Performance

Shares of ALAB opened at $101.29 on Monday. Astera Labs, Inc. has a 52-week low of $36.22 and a 52-week high of $147.39. The business has a fifty day moving average of $122.39 and a 200 day moving average of $81.91.

Analyst Ratings Changes

Several equities analysts have weighed in on ALAB shares. Deutsche Bank Aktiengesellschaft lifted their price target on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, November 5th. Northland Capmk upgraded shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 28th. JPMorgan Chase & Co. increased their price target on Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Citigroup began coverage on Astera Labs in a research report on Monday, November 18th. They issued a “buy” rating and a $120.00 price objective on the stock. Finally, Morgan Stanley cut their target price on Astera Labs from $142.00 to $114.00 and set an “equal weight” rating for the company in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, Astera Labs presently has an average rating of “Buy” and a consensus target price of $107.42.

Read Our Latest Stock Report on Astera Labs

Insider Buying and Selling

In other Astera Labs news, CFO Michael Truett Tate sold 16,000 shares of the company’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.84, for a total value of $1,885,440.00. Following the transaction, the chief financial officer now owns 1,412,888 shares of the company’s stock, valued at $166,494,721.92. This represents a 1.12 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Manuel Alba sold 11,000 shares of the stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total value of $1,292,500.00. Following the completion of the sale, the director now owns 456,863 shares in the company, valued at approximately $53,681,402.50. The trade was a 2.35 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 846,452 shares of company stock valued at $86,427,256.

Astera Labs Profile

(Free Report)

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.